JP2008509084A5 - - Google Patents

Download PDF

Info

Publication number
JP2008509084A5
JP2008509084A5 JP2007513303A JP2007513303A JP2008509084A5 JP 2008509084 A5 JP2008509084 A5 JP 2008509084A5 JP 2007513303 A JP2007513303 A JP 2007513303A JP 2007513303 A JP2007513303 A JP 2007513303A JP 2008509084 A5 JP2008509084 A5 JP 2008509084A5
Authority
JP
Japan
Prior art keywords
epitope
activated
polypeptide
cells
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007513303A
Other languages
English (en)
Japanese (ja)
Other versions
JP5710854B2 (ja
JP2008509084A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/016441 external-priority patent/WO2005110456A2/en
Publication of JP2008509084A publication Critical patent/JP2008509084A/ja
Publication of JP2008509084A5 publication Critical patent/JP2008509084A5/ja
Application granted granted Critical
Publication of JP5710854B2 publication Critical patent/JP5710854B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007513303A 2004-05-11 2005-05-11 Ｔ細胞死誘導エピトープ Expired - Fee Related JP5710854B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57016104P 2004-05-11 2004-05-11
US60/570,161 2004-05-11
PCT/US2005/016441 WO2005110456A2 (en) 2004-05-11 2005-05-11 T-cell death-inducing epitopes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012223627A Division JP2013049679A (ja) 2004-05-11 2012-10-05 Ｔ細胞死誘導エピトープ

Publications (3)

Publication Number Publication Date
JP2008509084A JP2008509084A (ja) 2008-03-27
JP2008509084A5 true JP2008509084A5 (enExample) 2008-06-26
JP5710854B2 JP5710854B2 (ja) 2015-04-30

Family

ID=35394670

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2007513303A Expired - Fee Related JP5710854B2 (ja) 2004-05-11 2005-05-11 Ｔ細胞死誘導エピトープ
JP2012223627A Pending JP2013049679A (ja) 2004-05-11 2012-10-05 Ｔ細胞死誘導エピトープ
JP2015093320A Expired - Fee Related JP6109234B2 (ja) 2004-05-11 2015-04-30 Ｔ細胞死誘導エピトープ

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2012223627A Pending JP2013049679A (ja) 2004-05-11 2012-10-05 Ｔ細胞死誘導エピトープ
JP2015093320A Expired - Fee Related JP6109234B2 (ja) 2004-05-11 2015-04-30 Ｔ細胞死誘導エピトープ

Country Status (20)

Country Link
US (3) US20060003940A1 (enExample)
EP (2) EP1751300B1 (enExample)
JP (3) JP5710854B2 (enExample)
KR (3) KR20130018989A (enExample)
CN (3) CN105777867A (enExample)
AR (1) AR048840A1 (enExample)
AU (1) AU2005244081B2 (enExample)
BR (1) BRPI0510561A (enExample)
CA (1) CA2565872C (enExample)
CL (1) CL2008003587A1 (enExample)
EC (1) ECSP067055A (enExample)
ES (1) ES2655833T3 (enExample)
IL (1) IL178837A (enExample)
MX (1) MXPA06012987A (enExample)
NO (1) NO20065648L (enExample)
NZ (3) NZ578356A (enExample)
RU (1) RU2412945C2 (enExample)
TW (3) TWI454275B (enExample)
UA (3) UA105492C2 (enExample)
WO (1) WO2005110456A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7744888B2 (en) 2001-08-03 2010-06-29 Abgenomics Cooperatief U.A. Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies
US20040116333A1 (en) 2001-08-03 2004-06-17 Rong-Hwa Lin Modulators of P-selectin glycoprotein ligand 1
UY28886A1 (es) 2004-05-10 2005-12-30 Boehringer Ingelheim Int Anticuerpos que consisten en polipéptidos y derivados conprendiendo tres secuencias conteniendo respectivamente los siguientes números de seq. id: 1-3 y 4-6; 7-9 y 10-12 y 13-15 ó 16-18
BRPI0510561A (pt) * 2004-05-11 2007-11-20 Abgenomics Corp epìtopos que induzem morte de célula t
WO2009093251A2 (en) * 2008-01-24 2009-07-30 Gavish-Galilee Bio Applications Ltd Reovirus vaccine based on sigma c protein sequence
CN116063522A (zh) 2011-06-13 2023-05-05 美国全心医药生技股份有限公司 抗psgl-1抗体及其用途
ES2880731T3 (es) 2016-01-08 2021-11-25 Altrubio Inc Anticuerpos anti-PSGL-1 tetravalentes y usos de los mismos
JP7244422B2 (ja) 2017-01-11 2023-03-22 ブリストル－マイヤーズ スクイブ カンパニー Ｐｓｇｌ－１アンタゴニスト及びその使用
SG11201907848YA (en) 2017-03-14 2019-09-27 Five Prime Therapeutics Inc Antibodies binding to vista at acidic ph
MX2020009786A (es) 2018-03-21 2020-10-12 Five Prime Therapeutics Inc Anticuerpos de union a supresor de la activacion de celulas t que contiene el dominio variable de inmunoglobulina (vista) a ph acido.
US12091462B2 (en) 2018-07-11 2024-09-17 Five Prime Therapeutics, Inc. Antibodies binding to vista at acidic pH

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
JPS61134325A (ja) * 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
US5866363A (en) 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4704692A (en) 1986-09-02 1987-11-03 Ladner Robert C Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5464778A (en) * 1989-03-08 1995-11-07 Board Of Regents Of The University Of Oklahoma Glycoprotein ligand for P-selectin and methods of use thereof
US5378464A (en) * 1989-03-08 1995-01-03 Board Of Regents Of The University Of Oklahoma Modulation of inflammatory responses by administration of GMP-140 or antibody to GMP-140
US5690933A (en) * 1989-05-31 1997-11-25 Glaxo Wellcome Inc. Monoclonal antibodies for inducing tolerance
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
KR100272077B1 (ko) 1990-08-29 2000-11-15 젠팜인터내셔날,인코포레이티드 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물
US5709859A (en) * 1991-01-24 1998-01-20 Bristol-Myers Squibb Company Mixed specificity fusion proteins
US6124267A (en) * 1991-02-05 2000-09-26 Southpac Trust Internationals, Inc. O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1
US6309639B1 (en) * 1991-02-05 2001-10-30 The Board Of Regents Of The University Of Oklahoma Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand
US5972625A (en) * 1991-05-06 1999-10-26 The Regents Of The University Of California Assays for inhibitors of leukocyte adhesion
US5843707A (en) * 1992-10-23 1998-12-01 Genetics Institute, Inc. Nucleic acid encoding a novel P-selectin ligand protein
WO1994014836A1 (en) * 1992-12-18 1994-07-07 Centocor, Inc. Peptide inhibitors of selectin binding
ES2126742T3 (es) * 1993-01-25 1999-04-01 Dana Farber Cancer Inst Inc Selectinas quimericas obtenidas mediante intercambio de dominios - sus usos.
WO1995014787A1 (en) * 1993-11-22 1995-06-01 Centocor, Inc. Peptide inhibitors of selecting binding
US6719972B1 (en) * 1994-06-03 2004-04-13 Repligen Corporation Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA4- specific antibodies
ES2208759T3 (es) 1995-08-03 2004-06-16 Board Of Regents Of The University Of Oklahoma O-glicanos inhibidores de la inflamacion mediada por selectina.
DE19629938C1 (de) 1996-07-24 1997-11-27 Gsf Forschungszentrum Umwelt E-Cadherin-Mutationen als Grundlage zur Diagnostik und Therapie humaner maligner Tumoren
ATE252602T1 (de) * 1996-08-27 2003-11-15 Chiron Corp Meningokokkus b-epitop ausbildende monoklonale antikoerper und deren verwendung zur herstellung von impfstoffzusammenstellungen
US5955259A (en) * 1996-12-19 1999-09-21 Brandeis University Method for assessing modulation of potassium ion channel activity
DE69837529T2 (de) * 1997-02-12 2007-07-26 Electrophoretics Ltd., Cobham Proteinmarker für lungenkrebs und deren verwendung
US6551994B1 (en) 1997-04-10 2003-04-22 Mcgill University Compounds and methods for inhibiting the interaction between α-catenin and β-catenin
PT1032674E (pt) 1997-11-21 2007-03-30 Serono Genetics Inst Sa Sequência genómica e polipéptidos (de chlamydia pneumoniae), seus fragmentos e suas utilizações, em particular para o diagnóstico, prevenção e tratamento de infacção
WO1999043353A2 (en) * 1998-02-26 1999-09-02 Boehringer Ingelheim Pharmaceuticals, Inc. Combination anti-selectin and immunosuppressant therapy
NZ528610A (en) 1998-10-30 2005-03-24 Inst Genetics Llc Inhibition of differentiation of cytotoxic T-cells by P-selectin ligand (PSGL) antagonists
DE19925199A1 (de) * 1999-06-01 2000-12-07 Medigene Ag Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
AU2001251612A1 (en) * 2000-04-14 2001-10-30 Millennium Pharmaceuticals, Inc. Roles of jak/stat family members in tolerance induction
AU2000274809A1 (en) * 2000-09-12 2002-03-26 Genetics Institute Llc Inhibition of stenosis or restenosis by p-selectin antagonists
US20040002450A1 (en) * 2000-12-29 2004-01-01 Janette Lazarovits Y17 - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
JP2005503756A (ja) * 2000-12-29 2005-02-10 サビエント ファーマシューティカルズ，インコーポレイティド 硫酸化部分を含むエピトープを含む単離分子、当該エピトープに対する抗体、及びその使用
US20040001839A1 (en) * 2000-12-29 2004-01-01 Avigdor Levanon Multimers - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
NZ512341A (en) * 2001-06-13 2004-02-27 Bayer Ag Polynucleotides between 15 and 100 base pairs in length coding for parapoxvirus ovis (PPVO)/vaccinia virus recombinant (VVOV) viral genome fragments
US20040116333A1 (en) 2001-08-03 2004-06-17 Rong-Hwa Lin Modulators of P-selectin glycoprotein ligand 1
US7744888B2 (en) 2001-08-03 2010-06-29 Abgenomics Cooperatief U.A. Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies
WO2003032925A2 (en) * 2001-10-19 2003-04-24 Cummings Richard D Glycosulfopeptide inhibitors and methods of use thereof
RU2005101621A (ru) * 2002-07-01 2005-11-20 Савиент Фармасьютикалс, Инк. (Us) Антитела и их применения
AU2003297573A1 (en) * 2002-11-27 2004-06-23 Cedric Francois Compositions and methods for treating transplants
US20050152906A1 (en) * 2003-06-30 2005-07-14 Avigdor Levanon Specific human antibodies
AU2004273807B2 (en) * 2003-09-15 2011-06-09 Abgenomics Cooperatief U.A. Modulators of P-Selectin Glycoprotein Ligand 1
UY28886A1 (es) 2004-05-10 2005-12-30 Boehringer Ingelheim Int Anticuerpos que consisten en polipéptidos y derivados conprendiendo tres secuencias conteniendo respectivamente los siguientes números de seq. id: 1-3 y 4-6; 7-9 y 10-12 y 13-15 ó 16-18
BRPI0510561A (pt) 2004-05-11 2007-11-20 Abgenomics Corp epìtopos que induzem morte de célula t
CN116063522A (zh) 2011-06-13 2023-05-05 美国全心医药生技股份有限公司 抗psgl-1抗体及其用途

Similar Documents

Publication Publication Date Title
JP2008509084A5 (enExample)
IL195338A (en) An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use
DE69718903T2 (de) Verwendung von aus osp-c abgeleiteten peptidefragmenten für diagnostische methoden
EP2287201A3 (en) RS7 antibodies
JP2005512507A5 (enExample)
JP2020517628A5 (enExample)
NO20010412D0 (no) Anvendelse av borreliacidal(e) epitoper av Borrelia burgdorferi ytre overflateprotein C som vaksine
TW200602071A (en) Methods for preventing and treating alzheimer's disease (ad)
WO2007070671A3 (en) Therapeutic methods for inhibiting tumor growth with dll4 antagonists
WO2005000244A3 (en) Methods and compositions for treating rheumatoid arthritis
JP2009529497A5 (enExample)
JP2013506425A5 (enExample)
Mathiesen et al. The dominant epitope of Borrelia garinii outer surface protein C recognized by sera from patients with neuroborreliosis has a surface-exposed conserved structural motif
Peng et al. Mosquito salivary allergen Aed a 3: cloning, comprehensive molecular analysis, and clinical evaluation
RU2006143689A (ru) Эпитопы, индуцирующие гибель т-клеток
JP2006158399A5 (ja) 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤
EP0463059A1 (en) Allergenic proteins from ragweed and uses therefor
McMillan et al. Identification and assessment of new vaccine candidates for group A streptococcal infections
JP2005512016A5 (enExample)
JP2005515981A5 (enExample)
WO2004041296A3 (en) Pharmaceutical composition comprising a tissue factor antagonist and protein c polypeptides
DE69333709D1 (de) T-zell epitope des raygraspollen-allergens
JP2004502782A5 (enExample)
AU2002242273B2 (en) Compositions of multimeric profilin for diagnosis and treatment of allergies
JP2005511088A5 (enExample)